No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / mortality
-
Breast Neoplasms / pathology
-
Data Interpretation, Statistical
-
Disease Progression
-
Disease-Free Survival
-
Drug Approval*
-
Female
-
Humans
-
Neoadjuvant Therapy* / adverse effects
-
Neoadjuvant Therapy* / mortality
-
Neoplasm Recurrence, Local
-
Reproducibility of Results
-
Risk Assessment
-
Risk Factors
-
Survival Analysis
-
Time Factors
-
Treatment Outcome
-
United States
-
United States Food and Drug Administration*